Archives

B (BPT) – According to the National Institutes of Health, nearly half of U.S. teenagers have experienced a mental health disorder at some point, with… Login to continue reading Login…

B DUBLIN, April 30, 2026 /PRNewswire/ — Keenova Therapeutics plc, a leading developer and manufacturer of branded therapeutics, announced today that it will report its first… Login to continue reading Login…

B BALTIMORE, April 30, 2026 /PRNewswire/ — T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced its financial results for the first quarter of 2026. The earnings… Login to continue reading Login…

B FIRST QUARTER 2026 FINANCIAL SUMMARY Net sales of $5.97 billion Earnings from continuing operations of $76 million Adjusted EBITDA (non-GAAP) from continuing operations of… Login to continue reading Login…

B Investment reinforces GameAbove’s long-term commitment to performance-driven innovation in global golf FORT MYERS, Fla., April 30, 2026 /PRNewswire/ — GameAbove Golf today announced it… Login to continue reading Login…

B The company continues its commitment to a green future with Switch recognition for 2025. TROY, Mich., April 30, 2026 /PRNewswire/ — North, a leader… Login to continue reading Login…

B Q1 Net Revenue of $2.9 billion with 21.4 million Active Customers BOSTON, April 30, 2026 /PRNewswire/ — Wayfair Inc. (“Wayfair,” “we,” or “our”) (NYSE: W),… Login to continue reading Login…

B NEW YORK, April 30, 2026 /PRNewswire/ — Blue Owl Capital Inc. (NYSE:OWL) (“Blue Owl”) today reported its financial results for the first quarter ended… Login to continue reading Login…

B BOSTON and SAN DIEGO, April 30, 2026 /PRNewswire/ — Brenig Therapeutics Inc. (Brenig), a clinical-stage biotechnology company advancing best-in-class therapies for neurodegenerative, neuroinflammatory, and cardiometabolic… Login to continue reading Login…

B PRINCETON, N.J., April 30, 2026 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit… Login to continue reading Login…